Member Exclusive

Nanotechnology utilized to deliver targeted treatments for lung infection

Researchers from Massachusetts Institute of Technology (Cambridge, MA, USA) have developed a targeted antimicrobial treatment, that dramatically reduces the number of bacteria in the lungs of mice infected with Pseudomonas aeruginosa.

Go to the profile of Rachel Coleby
Jul 20, 2017
0
0

Please sign in or register for FREE to view this content

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet. Start the conversation...